Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–9 of 9 results
Advanced filters: Author: Sagar Bhogaraju Clear advanced filters
  • After being used in the 1950s to treat morning sickness in pregnant women, with devastating effects, thalidomide and its derivatives (lenalidomide and pomalidomide) are now widely used in cancer therapy. New structural work from two groups gives insights into the basis for the teratogenicity and other clinical effects of these drugs.

    • Sagar Bhogaraju
    • Ivan Dikic
    News & Views
    Nature Structural & Molecular Biology
    Volume: 21, P: 739-740
  • Legionella pneumophila (LP) employs the metaeffector SidJ to suppress the toxicity of SdeA and other LP SidE effector family members by catalysing the glutamylation of the catalytic Glu residue. Here, the authors present the cryo-EM structures of SidJ in complex with SdeA in two different states, which together with mutagenesis analysis provide insights into the substrate recognition and the mechanism of protein glutamylation by SidJ.

    • Michael Adams
    • Rahul Sharma
    • Sagar Bhogaraju
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-12
  • Legionella pneumophila secretes hundreds of effectors to facilitate infection. Here, Sharma et al show that the virulence effector SidH adopts a unique α-helical conformation, leading to toxicity via tRNA binding site and resolve the structural basis of SidH regulation through ubiquitination.

    • Rahul Sharma
    • Michael Adams
    • Sagar Bhogaraju
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-17
  • A protein in the pathogenic bacterium Legionella pneumophila has been found to attach the modifying molecule ubiquitin to human proteins, using a mechanism that, surprisingly, does not involve cellular E1 and E2 enzymes. See Letter p.120

    • Sagar Bhogaraju
    • Ivan Dikic
    News & Views
    Nature
    Volume: 533, P: 43-44
  • This study uncovers the role of epigenetic H2A monoubiquitination in the mouse brain’s response to chronic cocaine use. It also identifies genetic variations in humans linked to H2A monoubiquitination, modifying susceptibility to cocaine addiction and aggression, and paving the way for tailored treatments.

    • Julian Cheron
    • Leonardo Beccari
    • Alban de Kerchove d’Exaerde
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-18